IBS Ad Puts Drug Promotion Under Scrutiny

dc.creator	Sweet, Melissa	en
dc.date.accessioned	2016-01-09T00:09:32Z	en
dc.date.available	2016-01-09T00:09:32Z	en
dc.date.created	2003-06-28	en
dc.date.issued	2003-06-28	en
dc.identifier	doi:10.1136/bmj.326.7404.1464-a	en
dc.identifier.bibliographicCitation	BMJ: British Medical Journal 2003 June 28; 326(7404): 1464	en
dc.identifier.uri	http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=IBS+ad+puts+drug+promotion+under+scrutiny&title=BMJ:+British+Medical+Journal+&volume=326&issue=7404&spage=1464&date=2003-06&au=Sweet,+Melissa	en
dc.identifier.uri	http://dx.doi.org/10.1136/bmj.326.7404.1464-a	en
dc.identifier.uri	http://hdl.handle.net/10822/999542	en
dc.format	Article	en
dc.language	en	en
dc.source	eweb:261127	en
dc.subject.classification	Drugs and Drug Industry	en
dc.subject.classification	Business Ethics	en
dc.title	IBS Ad Puts Drug Promotion Under Scrutiny	en
dc.provenance	Citation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.	en
dc.provenance	Citation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.	en

Related items